welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Carcinoma Colon and Managementhttp://www.slideshare.net/shivkishor/car...
-
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsMalignant transformation of adenomas of ...
-
Mucosectomy with Handsewn Anastomosis Reduces the Risk of Adenoma Formation in the Anorectal Segment After Restorati...OBJECTIVE : The study compared the risk ...
-
Is Laparoscopic Surgery an Option to Support Prophylactic Colectomy in Adolescent Patients with Familial Adenomatous...BACKGROUND : Prophylactic surgery is sti...
-
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous PolyposisFamilial Adenomatous Polyposis (FAP) is ...
-
PTSD common in patients with familial adenomatous polyposisPosttraumatic stress disorder is common ...
-
Management of Duodenal Adenomatosis in FAP: Single Centre ExperienceDuodenal and ampullary carcinoma in fami...